Inventiva S.A. (IVA) Analyst/Investor Day Transcript
Source: SeekingAlpha
2025-10-08 19:16:38 ET
Inventiva S.A. (IVA) Analyst/Investor Day October 8, 2025 11:30 AM EDT
Company Participants
Mark Pruzanski
Andrew Obenshain - CEO & Director
Jason Campagna - President of Research and Development & Chief Medical Officer
Martine Zimmermann - Executive VP of Regulatory Affairs & Quality Assurance
...
Read the full article on Seeking Alpha
For further details see:
Inventiva S.A. (IVA) Analyst/Investor Day Transcript
Inventiva
NASDAQ: IVEVF
IVEVF Trading
-1.44% G/L:
$4.12 Last:
1,000 Volume:
$4.12 Open:
IVEVF Latest News
February 04, 2026 04:00:00 pm
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
December 17, 2025 04:00:00 pm
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
IVEVF Stock Data
$568,234,603
18,487,278
N/A
14
N/A
Biotechnology & Life Sciences
Healthcare
FR
Daix
